Lavipharm at CPhI Worldwide 2021

Peania, November 12, 2021 – Lavipharm participated in CPhI Worldwide 2021, the largest exhibition in the pharmaceutical industry worldwide, uniting thousands of pharma suppliers and buyers across the full supply chain from around the world. The event took place in Milan from 9 to 11 November and online from 25 October to 19 November 2021.

More specifically, more than 1,400 exhibitors from 170 countries came to connect, learn and be informed about current developments covering the full spectrum of the pharma industry. During the three-day event, Lavipharm participated as an exhibitor. The Lavipharm booth became the meeting point, where the company’s executives had the opportunity to inform industry professionals about the complete portfolio of high quality pharmaceutical products and services of the Group. The spearhead is the category of transdermal drug delivery systems, which are produced at Lavipharm’s plant facilities in Peania and exported internationally.

“We are proud to be part of the CPhI Worldwide 2021, the largest international pharmaceutical event, which is attracting the interest of the global pharma business. Through our presence, we have managed to successfully communicate Lavipharm’s innovative pharmaceutical products. In addition, we further strengthened our relations with existing partners and laid the foundations for new profitable partnerships that will enhance our presence in even more markets “, said Mr. Panagiotis Giannouleas, Chief Operating Officer & Country Manager of Lavipharm.

Lavipharm, with a history of 110 years, is today an integrated Group engaged in the research, development, production, marketing and distribution of pharmaceutical, OTC and dermocosmetic products in Greece with a strong international activity.